Soon will have $20 range...
We are heading for better results on DCVax Direct and its better than ICPT which open $440 after close at $70 in March 2014
Don't worry AF has to keep his shiiity mouth shut for ever on NWBO after that Shity article he sends out on NWBO largest booth and DCVax Direct results.
By 27th June NWBO shall be at least $1Billion Mkt Cap and for which the stock price has to be $20 or above.
The Russell 3,000 Index covers both the Russell 2,000 Index for small-cap growth stocks and the Russell 1000 Index for larger-cap companies. The Russell Global Indexes reflect the performance of over 10,000 securities in 47 countries.
Selection for inclusion in these indexes is based upon market capitalization and other market factors relating to a company and its stock. Membership in these indexes is updated annually, and remains in place for one year.
Russell Indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $5.2 trillion in assets currently are benchmarked to Russell Indexes.
"We are very gratified to be added to both the Russell Global and the Russell 3000 Indexes," commented Linda Powers, CEO of NW Bio. "It is an important reflection of NW Bio's strong progress and accelerating momentum on multiple fronts (both on the science and clinical fronts and on the business and finance fronts). Inclusion in these indexes will also increase awareness of NW Bio's strong performance among institutional fund managers both in the US and abroad."
Russell Indexes Reconstitution
Russell Investments has posted its official preliminary lists of companies set to join or leave the Russell Global Index, Russell 3000 Index and Russell Microcap Index when the annual reconstitution for its U.S. equity indexes concludes on June 27.
Each June, Russell completely realigns its family of global equity indexes to reflect market changes in the past year.
This year’s rebalance will impact approximately $5.2 trillion in assets benchmarked to and nearly $800 billion in assets invested in institutional and retail investment products based on the Russell Indexes, according to Russell.
The largest three companies in the Russell U.S. Indexes in terms of total market capitalization at this year’s reconstitution are Apple ($545.3 billion), ExxonMobil ($431.7 billion) and Google ($385.6 billion).
The largest company in the Russell Global ex-U.S. Index is now Netherlands-based Royal Dutch Shell PLC, with a total market cap of $254.5 billion, replacing PetroChina Co.
Of the 846 new additions to the Russell Global Index at reconstitution (41 of which are IPOs), the U.S. gained the largest number of new companies through the reconstitution process (148), followed by Taiwan (68), China (67), Japan (59) and the United Kingdom (56).
The U.S. led all Russell Global Index country constituents in IPO additions at reconstitution with 27, followed by the U.K. (7) and China (5). Also, as previously announced on March 3, Egypt, formerly classified as an emerging market, will enter the Russell Frontier Index effective June 27.
Veracity From Academia on Tumor Lysate-Pulsed Dendritic Cell (DC) Vaccines (analog to NWBO's DCVax-L), and Activated, Intratumorally Injected DC Vaccines (analog to NWBO's DCVax-Direct):
Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst. These types of traders like to get in well before a large spike, so it's always a smart move to monitor unusual volume.
Total Shares Held: 58
New Positions: 17
Increased Positions: 35
Another approach is to use an interim analysis of the surrogate endpoint data as the basis for accelerated approval, with continuation of the randomized trials during the time period when the surrogate endpoint and interim safety data are being: (1) analyzed, (2) prepared for submission to FDA, and (3) reviewed by FDA. When the ultimate clinical outcome can be expected over this additional timeframe, the data to verify the clinical benefit may be nearly complete by the time of accelerated approval. " Guidelines
Material Events | NWBO Message Board Posts
45 mins ago - (or perhaps you're suggesting the DSMB made the rec to halt, the Sponsor approached the FDA who advised continue, and they took the FDA's
Sr. Columnist at TheStreet, aka the Col. Jessep of biotech/drug stocks. Data Are. I curse. Said one analyst: The likes of Adam Feuerstein attack viciously
4 hours ago - BETHESDA, Md., June 16, 2014 /PRNewswire/ -- Northwest ... a 60-patient Phase I/II trial with DCVax-Direct for all inoperable solid tumors cancers. ... with extraordinary upside potential that are flying under Wall Street's radar.